Plant Tissue Culture: Techniques, Steps & Applications

This segment covers the complete process of industrial plant production through micropropagation. The biofactory produces 1 million genetically improved sugarcane seedlings monthly using tissue culture techniques. Technicians surgically extract meristem tissue, which is placed in nutrient-rich media with plant hormones under controlled conditions. A bioractor system automates monitoring and nutrient delivery, enabling accelerated multiplication at higher rates with fewer personnel. After 15 days, each tissue produces 15 seedlings, and over 6 months, each piece can yield 1,000 seedlings. The seedlings then undergo hardening in greenhouses for 30-60 days to develop stronger root systems before field planting.

Bioreactors offer a more efficient alternative to traditional jar-based tissue culture. Unlike jars that use agar as a gelling agent (which accounts for approximately 80% of tissue culture costs), bioreactors use liquid medium. The system consists of two containers: one holding liquid medium at the bottom and another containing explants at the top. Compressed air pushes the medium upward, immersing the plant tissues periodically. Parameters like immersion frequency and duration can be controlled, along with air injection to refresh the environment around explants. This system achieves multiplication rates exceeding 10:1, producing hundreds or thousands of plants from initial explants while reducing per-plant costs to approximately $0.50.

Automation and robotization in micropropagation laboratories improve efficiency, sterility, and scalability by handling repetitive tasks like transplanting, pot washing, and substrate filling, while human operators remain essential for quality control and complex decision-making, particularly since not all stages of the process can be fully automated due to the variability of plant species and the need for experienced judgment.

This segment explains the scale-up process in biotechnology. The instructor describes the transition from laboratory-scale production (pilot scale, 10-20 liters) to industrial-scale manufacturing (bioreactors, 100-1000 liters). A bioreactor is a vessel that provides a controlled environment for growing biological organisms (bacteria, yeast, plant cells, or animal cells) to produce desired products. The instructor describes key components: inlet for adding raw materials, outlet for removing products, motor with impellers for mixing, baffles for improved mixing efficiency, foam breakers to prevent foam formation, temperature control, pH monitoring, and sterile air supply. The instructor distinguishes between stirred tank bioreactors (curved base, impellers) and sparged bioreactors (flat base, spargers for oxygen supply).

The temporary immersion bioreactor system uses two connected vessels—a 6-liter plant vessel and a 3-liter media vessel—with an air compressor that periodically pumps air to circulate liquid media. This automated system achieves 1:1200 multiplication ratios in three weeks, compared to natural propagation rates of 1:2-1:10. It enables efficient mass propagation of energy cane, producing 800 plantlets per vessel, and reduces labor while maintaining high multiplication efficiency.

Plant cell, tissue, and organ cultures provide alternatives to whole-plant cultivation for producing secondary metabolites. Plant cells are chemically totipotent and can produce the full range of compounds found in intact plants. Key production methods include callus cultures, cell suspension cultures, immobilized cell systems for continuous bioreactor operation, and biotransformation for converting lower-value compounds to higher-value ones. Hairy root cultures, obtained through Agrobacterium rhizogenes-mediated transformation, can produce secondary metabolites at 40-42 fold increases when challenged with elicitors. Commercially produced compounds include shikonin from Lithospermum erythrorhizon, ginseng, anthocyanins, and taxol. These technologies have been scaled up in Japan, Germany, Switzerland, and the US for commercial production of pharmaceutical and cosmetic molecules.

Cell suspension culture involves growing cells in liquid medium with continuous agitation using shakers or rotation mechanisms. Viability is tested using fluorescent diacetate staining for 24-48 hours. After fusion, selection of hybrids is crucial, with fusion products without nuclei called cybrids. Cell suspension cultures produce valuable secondary metabolites including flavonoids, phenolic compounds, recombinant proteins, enzymes, hormones, and coloring agents. Indole alkaloids from plants like Rosy are prominent examples. Large-scale commercial production is achieved using bioreactors, which provide controlled environments for growing cells at industrial scale. This technology enables production of compounds that would be difficult to obtain from traditional plant sources, with applications in pharmaceuticals, cosmetics, and industrial manufacturing.

Secondary metabolites are byproducts of primary metabolism not directly involved in growth, including alkaloids in plants and antibiotics in microbes. Two strategies enable commercial production: (1) Gene overexpression - transgenic plants overexpressing biosynthetic enzymes increase end product yield, successfully applied to alkaloid production; (2) Hairy root culture - Agrobacterium rhizogenes induces secondary root formation, creating reservoirs for metabolite accumulation. Plants function as natural bio reactors, producing edible vaccines, therapeutic proteins, and biodegradable plastics through recombinant DNA technology.

Cell suspension culture is a biotechnological technique where plant cells are grown in liquid medium under agitation, enabling the production of secondary metabolites such as alkaloids, flavonoids, terpenoids, and phenolic compounds that are not essential for normal plant growth but have valuable pharmaceutical applications; this method can be scaled up using bioreactors with strategies like elicitation and immobilization to enhance metabolite yield.

Suspension culture is a biotechnological technique for producing secondary metabolites by growing plant cells in liquid media without agar. The primary application is producing medicinal compounds like shikonin (first biotechnologically produced compound, patented by Pfizer in 1952 for neurological disorders). Key advantages include non-destructive cell handling, better mineral treatment control, and scalability. Tween 20 detergent is used to release alkaloids from cells by increasing membrane permeability. The technique allows for continuous harvesting of extracellular metabolites by simply replacing media, making it commercially viable for large-scale production.

Cryopreservation using vitrification-based techniques enables long-term conservation of plant species, including recalcitrant seeds, vegetatively propagated plants, and endangered species, by rapidly cooling plant materials to liquid nitrogen temperatures (-196°C) to prevent ice crystal formation; successful applications include Fenugreek, Anise, Marjoram seeds showing equivalent germination rates to non-cryopreserved seeds, and Silvery Whitlow Wort, Tulip, and Polyanthus Narcissus shoot tips achieving 77%, 67%, and 83% regrowth respectively using the V cryo-plate technique.

Cryopreservation is a long-term conservation technique for recalcitrant plant germplasm (species with seeds that cannot be stored conventionally) that involves freezing biological materials in liquid nitrogen at -196°C to prevent the formation of intracellular ice crystals, which are the primary cause of viability loss; modern methods like droplet vitrification and cryopreservation in aluminum plaques (DRO and CV) use rapid cooling and rewarming rates (4000°C/min and 3000°C/min) to achieve indefinite storage while maintaining tissue viability.

Germplasm, defined as living plant tissue containing all genetic material, can be conserved for long periods using cryopreservation—a technique involving storage in liquid nitrogen at -196°C—which stops metabolic activity and cell division; this method employs cryoprotectants to prevent ice crystal formation and damage, with viability assessed by calculating the percentage of cells/organs surviving the process, making it highly valuable for preserving endangered plant species and providing raw material for plant breeders.

Cryopreservation serves critical conservation purposes for endangered plant species. It enables long-term storage of genetic material including seeds, pollen, somatic embryos, and in vitro cultures indefinitely. This technology supports conservation programs by preserving genetic diversity for future use, enabling reintroduction into native habitats, and facilitating distribution to botanical gardens worldwide. Successful recovery from cryopreservation has been demonstrated with materials stored for over 15 years, producing viable plants within months of thawing when handled properly.

Cryopreservation technology allows for the long-term storage of living cells from endangered species by using cryoprotectants to prevent ice crystal formation and liquid nitrogen at -196°C to halt cellular metabolism, enabling future genetic studies, cloning, and species reintroduction efforts for critically endangered mammals like Mexican grey wolves and red wolves.

Somaclonal variation has four major applications in agriculture: (1) Disease resistance - selecting plants with resistant traits from regenerated populations; (2) Stress tolerance - developing plants that withstand salt, drought, and other environmental stresses; (3) Secondary metabolite enhancement - increasing production of valuable compounds in medicinal and industrial plants; (4) Rapid crop improvement - achieving faster variety development than conventional breeding methods. These applications make somaclonal variation a valuable tool for modern crop improvement programs.

Somaclonal variation represents heritable genetic changes in plants arising from tissue culture, combining somatic cells, clonal propagation, and transmissible mutations detectable as genetic or phenotypic traits. Two isolation strategies exist: non-selective screening of regenerated plants versus targeted in vitro selection using selective agents like pathogens, toxins, or environmental stresses. The in vitro approach involves explant culture, callus proliferation, exposure to selective agents, subculturing for resistance enrichment, shoot regeneration, pathogen challenge testing, acclimatization, progeny verification across generations, and agronomic evaluation. Detection employs morphological analysis, cytological chromosome studies, DNA content measurement, and gel electrophoresis for enzyme/protein profiling. Agricultural applications include salt tolerance in tobacco, water logging resistance in tomato, drought-tolerant rice, temperature stress tolerance in pepper, and aluminum toxicity resistance in sorghum.

Somaclonal variations serve critical agricultural purposes: generating novel plant varieties, developing insect-resistant plants, creating disease-resistant cultivars, improving plant quality including seed quality, producing herbicide-resistant plants, and cultivating abiotic stress-resistant plants capable of tolerating temperature extremes, salt stress, and water stress. The induction process involves treating callus tissue with physical or chemical mutagens, followed by organogenesis and plant regeneration. Key influencing factors include plant genotype, explant source, culture duration, and growth regulator composition (particularly 2,4-D, ABA, and BAP).

Somaclonal variation refers to genetic variations that arise during in vitro plant tissue culture, caused by factors such as chromosome number/structure changes, ploidy alterations, gene mutations, and environmental conditions like culture medium composition and growth regulator ratios; these variations can be either beneficial (e.g., increased sugar content in sugarcane, herbicide resistance) or harmful, and are selected through in vivo (field observation) or in vitro (stress treatment) methods to develop improved crop varieties.

In vitro selection strategically uses somaclonal variation for plant breeding. The process involves: inducing callus formation from explants, subculturing multiple times to increase variation probability, applying selective pressures (mannitol for drought stress, low temperatures for cold tolerance, high salinity for salt tolerance), and allowing only resistant calli to survive. The selection process is essentially random - some calli survive by chance and may possess beneficial mutations. After selection, surviving calli are regenerated into plants through organogenesis or embryogenesis, then adapted to ex vitro conditions and tested to confirm resistance. Somaclonal variation arises from oxidative stress in tissue culture conditions, originating from explant wounding, sterilization procedures, medium composition, or growth conditions. This stress produces reactive oxygen species that cause mutations at DNA, protein, or chromosomal levels. While undesirable for micropropagation (where genetic fidelity is essential), somaclonal variation is valuable for plant breeding programs, enabling generation of genetic variability that cannot be obtained through sexual crossing and facilitating development of new commercial varieties adapted to specific environmental stresses.